Activating the patient’s immune system
to fight cancer
The 30-month data from the mesothelioma trial was released December 2021. See press release here.
For a video presentation of the 24-month data from June 2021, please see links below:
Targovax announced its fourth quarter 2022 results on Thursday 16 February 2023.
Webcast: 10:00 a.m. CET the same day
For a company presentation in Norwegian, please see video below.